Contemporary management of migrainous disorders in pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 22, Issue 6, 2010, Pages 437-445

  Contag, Stephen A ^a   Bushnell, Cheryl ^b  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

beta blockers and antiepileptic drugs; migraine; pregnancy; prophylaxis; triptans

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; FLUOXETINE; HYDRALAZINE; HYDROCODONE; IBUPROFEN; INDOMETACIN; ISRADIPINE; LAMOTRIGINE; METHYLDOPA; METOCLOPRAMIDE; NICARDIPINE; ONDANSETRON; OXCARBAZEPINE; PARACETAMOL; PIZOTIFEN; PROCHLORPERAZINE; PROPRANOLOL; SUMATRIPTAN; TIAGABINE; TIZANIDINE; TOPIRAMATE; VALPROIC ACID; VERAPAMIL; VIGABATRIN; ZONISAMIDE;

BEHAVIOR MODIFICATION; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FOOD AND DRUG ADMINISTRATION; HUMAN; LONGITUDINAL STUDY; MIGRAINE; NAUSEA AND VOMITING; PHYSIOTHERAPY; PREDICTION; PRIORITY JOURNAL; REVIEW;

BEHAVIOR THERAPY; FEMALE; FETUS; HUMANS; MIGRAINE DISORDERS; PHYSICAL THERAPY MODALITIES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 78449251123     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3283404e06     Document Type: Review

References (81)

1. The International Classification of Headache Disorders: 2nd ed. Cephalalgia. 2004; 24 Suppl 1: 9-160.
2. Nezvalova-Henriksen K, Spigset O, Nordeng H. Maternal characteristics and migraine pharmacotherapyduring pregnancy: cross-sectional analysisof data from a large cohort study. Cephalalgia 2009; 29:1267-1276.
3. Loder E. Migraine in pregnancy. Semin Neurol 2007; 27:425-433.
4. Melhado EM, Maciel JA Jr, Guerreiro CA. Headache during gestation: evaluation of1101 women. Can J Neurol Sci 2007; 34:187-192.
5. Lucas S. Medication use in the treatment of migraine during pregnancy and lactation. Curr Pain Headache Rep 2009; 13:392-398.
6. Marcus DA. Managing headache during pregnancy and lactation. Expert Rev Neurother 2008; 8:385-395.
7. Chen TC, Leviton A. Headache recurrence in pregnant women with migraine. Headache 1994; 34:107-110.
8. Maggioni F, Rossi P, Casson S, et al. Initially migraine-like manifestation of a ruptured spinal arteriovenous malformation. Cephalalgia 1 995; 15:237-240.
9. Marcus DA, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999; 39:625-632.
10. Sances G, Granella F, Nappi RE, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23:1 97-205.
11. Adeney KL, Williams MA, Miller RS, et al. Risk of preeclampsia in relation to maternal history of migraine headaches. J Matern Fetal Neonatal Med 2005; 18:167-172.
12. Marcoux S, Berube S, Brisson J, Fabia J. History of migraine and risk of pregnancy-induced hypertension. Epidemiology 1992; 3:53-56.
13. Sanchez SE, Qiu C, Williams MA, et al. Headaches and migraines are associated with an increased risk of preeclampsia in Peruvian women. Am J Hypertens 2008; 21:360-364.
14. Facchinetti F, Allais G, Nappi RE, et al. Migraine isariskfactorforhypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia 2009; 29:286-292.
15. Moore MP, Redman CW. Case-control study of severe preeclampsia of early onset. Br Med J (Clin Res Ed) 1983; 287:580-583.
16. Banhidy F, Acs N, Horvath-Puho E, Czeizel AE. Pregnancy complicationsand delivery outcomes in pregnant women with severe migraine. Eur J Obstet Gynecol Reprod Biol 2007; 134:157-163.
17. Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. Br Med J 2009; 338:b664.
18. Scher AI, Terwindt GM, Picavet HS, et al. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005; 64:614-620.
19. Facchinetti F, Allais G, D'Amico R, et al. The relationship between headache and preeclampsia: a case-control study. Eur J Obstet Gynecol Reprod Biol 2005; 121:143-148.
20. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, andthe riskofstroke in women: a prospective study. Neurology 2005; 64:1020-1026.
21. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106:509-516.
22. Marcus DA, Scharff L, Turk DC Nonpharmacological management of head-aches during pregnancy. Psychosom Med 1995; 57:527-535.
23. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 2005; 45:904-910.
24. Busch V, Gaul C. Exercise in migraine therapy: is there any evidence for efficacy? A critical review. Headache 2008; 48:890-899.
25. Christian P, West KP Jr, Katz J, et al. Cigarette smoking during pregnancy in rural Nepal. Risk factors and effects of beta-carotene and vitamin A supple-mentation. Eur J Clin Nutr 2004; 58:204-211.
26. Mulleners WM, Chronicle EP. Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia 2008; 28:585-597.
27. Nezvalova-Henriksen K, Spigset O, Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 2010; 50:563-575.
28. O'Quinn S, Ephross SA, Williams V, et al. Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 1999; 263 (1-2):7-12.
29. Alano MA, Ngougmna E, Ostrea EM Jr, Konduri GG. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 2001; 107:519-523.
30. Kozer E, Nikfar S, Costei A, et al.Aspirin consumption duringthefirsttrimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002; 187:1623-1630.
31. Persky V, Piorkowski J, Hernandez E, et al. Prenatal exposure to acetamino-phen and respiratory symptoms in the first year of life. Ann Allergy Asthma Immunol 2008; 101:271-278.
32. Kang EM, Lundsberg LS, Illuzzi JL, Bracken MB. Prenatal exposure to acetaminophen and asthma in children. Obstet Gynecol 2009; 114:1295-1306
33. Reprotox. Available from: www.reprotox.org.
34. Einarson A, Maltepe C, Navioz Y, et al. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 2004; 111:940-943.
35. Redmond GP. Propranolol and fet al growth retardation. Semin Perinatol 1982; 6:142-147.
36. MacGregor EA. Migraine in pregnancy and lactation: a clinical review. J Fam Plann Reprod Healthcare 2007; 33:83-93.
37. Saper JR, Silberstein SD, Lake AE 3rd, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994; 34:497-502.
38. Krymchantowski AV, Silva MT, Barbosa JS, Alves LA. Amitriptyline versus amitriptyline combined with fluoxetine in the preventive treatment of trans-formed migraine: a double-blind study. Headache 2002; 42:510-514.
39. D'Amico D. Antiepileptic drugs in the prophylaxis of migraine, chronic head-ache forms and cluster headache: a review of their efficacy and tolerability. Neurol Sci 2007; 28 (Suppl 2):S188-S197.
40. Kohlenberg RJ, Cahn T. Self-help treatment for migraine headaches: a controlled outcome study. Headache 1981; 21:196-200.
41. Koseoglu E, Akboyraz A, Soyuer A, Ersoy AO. Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia 2003; 23:972-976.
42. Topacoglu H, Karcioglu O, Yuruktumen A, et al. Impact of Ramadan on demographics and frequencies of disease-related visits in the emergency department. Int J Clin Pract 2005; 59:900-905.
43. Butera G, Biondi-Zoccai GG, Carminati M, et al. Systematic reviewand meta-analysis of currently available clinical evidence on migraine and patent fora-men ovale percutaneous closure: much ado about nothing? Catheter Car-diovasc Interv 2010; 75:494-504.
44. Woods TD, Harmann L, Purath T, et al. Small-and moderate-size right-to-left shunts identified by saline contrast echocardiography are normal and un-related to migraine headache. Chest 2010; 138:264-269.
45. Mathew NT. Dynamic optimization of chronic migraine treatment: current and future options. Neurology 2009; 72 (5 Suppl):S14-S20
46. FDA. New proposal for drug labelling in pregnancy. 2008; Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentRe-sources/ Labeling/ucm093310.htm.
47. Hilaire ML, Cross LB, Eichner SF. Treatment of migraine headaches with sumatriptan in pregnancy. Ann Pharmacother 2004; 38:1726-1730.
48. Nezvalova-Henriksen K, Spigset O, Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 2010; 50:563-575.
49. Cunningham FG. Williamsobstetrics. 23rd ed. New York: McGraw-Hill Profe-ssional; 2009. pp. 266-268.
50. Olesen C, Steffensen FH, Sorensen HT, et al. Pregnancy outcome following prescription forsumatriptan. Headache 2000; 40:20-24.
51. Soldin OP, Dahlin J, O'Mara DM. Triptans in pregnancy. Ther Drug Monit 2008; 30:5-9.
52. Cunnington M, Ephross S, Churchill P. The safety of sumatriptan and naratriptan in pregnancy: what have we learned? Headache 2009; 49:1414-1422.
53. Li DK, Liu L, Odouli R. Exposure to nonsteroidal anti-inflammatory drugs during pregnancyand riskofmiscarriage: population based cohortstudy. Br Med J 2003; 327:368.
54. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopra-mide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med 1996; 14:262-264.
55. ACP. Transfer of drugsand other chemicals into human milk. Pediatrics 2001; 108:776-789.
56. Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991; 31:333-340.
57. Marcus DA. Pregnancy and chronic headache. Expert Opin Pharmacother 2002; 3:389-393.
58. Limmroth V, Michel MC. The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers. Br J Clin Pharmacol 2001; 52:237-243.
59. Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia 2002; 22:491-512.
60. ACOG. Topiramate (topamax) for prevention of migraine. Obstet Gynecol 2005/05/03ed2005; 1136-1137.
61. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2003; CD002863.
62. Waterman EJ, Magee LA, Lim KI, et al. Do commonly used oral antihyperten-sives alter fet al or neonatal heart rate characteristics? A systematic review. Hypertens Pregnancy 2004; 23:155-169.
63. Tomson T, Battino D.Teratogenic effects ofantiepileptic medications. Neurol Clin 2009; 27:993-1002.
64. Silberstein SD, Lipton RB, Dodick DW, et al. Efficacyand safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007; 47:170-180.
65. Mathew NT. Antiepileptic drugs in migraine prevention. Headache 2001; 41 (Suppl 1):S18-S24.
66. Mathew NT. The prophylactic treatment of chronicdaily headache. Headache 2006; 46:1552-1564.
67. Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 2003; 4:310-317.
68. Mathew NT, Rapoport A, Saper J, et al. Efficacy of gabapentin in migraine prophylaxis. Headache 2001; 41:119-128.
69. Spira PJ, Beran RG. Gabapentin in the prophylaxisofchronicdaily headache: a randomized, placebo-controlled study. Neurology 2003; 61:1753-1759.
70. Yurekli VA, Akhan G, Kutluhan S, et al. The effect of sodium valproate on chronic daily headache and itssubgroups. J Headache Pain 2008; 9:37-41.
71. Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 2009; 28:1-10.
72. Bruno MK, Harden CL. Epilepsy in pregnant women. Curr Treat Options Neurol 2002; 4:31-40.
73. Hunt S, Russell A, Smithson WH, et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2008; 71:272-276.
74. Saper JR, Lake AE 3rd, Cantrell DT, et al. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 2002; 42:470-482.
75. Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005; 192:932-936. (Pubitemid 40311292)
76. Santone G, Ricchi G, Rocchetti D, et al. Is the exposure to antidepressant drugs in early pregnancy a riskfactor for spontaneous abortion? A review of available evidences. Epidemiol Psichiatr Soc 2009; 18:240-247.
77. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354:579-587. (Pubitemid 43209105)
78. Andrade SE, McPhillips H, Loren D, et al. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2009; 18:246-252.
79. FDA. Public Health Advisory: treatment challenges of depression in pregnancy and the possibility of persistent pulmonary hypertension in newborns. 2009; Available from: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvi- sories/ucm124348.htm.
80. Bakker MK, Kerstjens-Frederikse WS, Buys CH, et al. First-trimester use of paroxetine and congenital heart defects: a population-based case-control study. Birth Defects Res A Clin Mol Teratol 2010; 88:94-100.
81. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of majordepression during pregnancy in women who maintain ordiscontinue antidepressant treatment. J Am Med Assoc 2006; 295:499-507.